Access Bio Valuation
| 950130 Stock | KRW 5,540 170.00 2.98% |
At this time, the firm appears to be overvalued. Access Bio shows a prevailing Real Value of W4888.8 per share. The current price of the firm is W5540.0. Our model approximates the value of Access Bio from analyzing the firm fundamentals such as return on equity of 108.02, and Profit Margin of 0.40 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Access Bio's price fluctuation is very steady at this time. Calculation of the real value of Access Bio is based on 3 months time horizon. Increasing Access Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Access Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Access Stock. However, Access Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5540.0 | Real 4888.8 | Hype 5540.0 | Naive 5745.84 |
The real value of Access Stock, also known as its intrinsic value, is the underlying worth of Access Bio Company, which is reflected in its stock price. It is based on Access Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Access Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Access Bio helps investors to forecast how Access stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Access Bio more accurately as focusing exclusively on Access Bio's fundamentals will not take into account other important factors: Access Bio Total Value Analysis
Access Bio is presently estimated to have takeover price of 1.03 T with market capitalization of 292.03 B, debt of 10.13 M, and cash on hands of 167.93 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Access Bio fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.03 T | 292.03 B | 10.13 M | 167.93 M |
Access Bio Investor Information
About 25.0% of the company shares are owned by insiders or employees . The company has Price/Earnings (P/E) ratio of 149.71. Access Bio had not issued any dividends in recent years. Based on the analysis of Access Bio's profitability, liquidity, and operating efficiency, Access Bio is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Access Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Access Bio has an asset utilization ratio of 118.38 percent. This suggests that the Company is making W1.18 for each dollar of assets. An increasing asset utilization means that Access Bio is more efficient with each dollar of assets it utilizes for everyday operations.Access Bio Ownership Allocation
Access Bio holds a total of 26.79 Million outstanding shares. Access Bio retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Access Bio Profitability Analysis
The company reported the revenue of 441.37 M. Net Income was 166.09 M with profit before overhead, payroll, taxes, and interest of 90.63 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Access Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Access Bio and how it compares across the competition.
About Access Bio Valuation
The stock valuation mechanism determines Access Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Access Bio. We calculate exposure to Access Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Access Bio's related companies.8 Steps to conduct Access Bio's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Access Bio's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Access Bio's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Access Bio's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Access Bio's revenue streams: Identify Access Bio's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Access Bio's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Access Bio's growth potential: Evaluate Access Bio's management, business model, and growth potential.
- Determine Access Bio's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Access Bio's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Access Stock analysis
When running Access Bio's price analysis, check to measure Access Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Access Bio is operating at the current time. Most of Access Bio's value examination focuses on studying past and present price action to predict the probability of Access Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Access Bio's price. Additionally, you may evaluate how the addition of Access Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |